Gastric emptying scintigraphy is the gold-standard test for gastroparesis – delayed emptying of food from stomach to small intestine. Procedure – patient eats standardized meal (typically egg sandwich or other solid meal) labeled with small amount of radioactive tracer (technetium-99m sulfur colloid); patient stands or sits in front of gamma camera; images taken at 0, 1, 2, and 4 hours after meal; computer calculates percentage of meal remaining in stomach at each time point; total study about 4 hours. Normal results – less than 10% retention at 4 hours. Abnormal (gastroparesis) – more than 10% at 4 hours (mild), more than 25% (moderate), more than 50% (severe). Other tests – breath tests (13C-octanoic acid, 13C-spirulina) measure breath isotopes; less common; comparable accuracy. Wireless motility capsule (SmartPill) – swallowed capsule measures pressure, pH, temperature; alternative non-radioactive option. For diabetes patients – typical recommendation if symptoms suggestive (nausea, early satiety, vomiting, postprandial fullness, unexplained glycemic variability). Delayed stomach emptying due to nerve damage. Pathophysiology – chronic hyperglycemia damages vagus nerve (autonomic neuropathy) controlling stomach motility; food empties slowly from stomach; affects 5-50% of long-duration diabetes (variable estimates depending on definition; many cases mild and asymptomatic). Symptoms – nausea, vomiting, early satiety (feel full after few bites), postprandial fullness, abdominal pain, bloating, weight loss, GERD-like symptoms, anorexia. Diabetes-specific impact – erratic blood sugar (mismatch between insulin timing and food absorption); difficult medication timing; bezoars (food masses in stomach); malnutrition; severely impaired quality of life in severe cases. Predisposing factors – long-duration diabetes (10+ years), poorly controlled blood sugar, other diabetic complications (retinopathy, nephropathy, neuropathy), female sex, type 1 more than type 2 traditionally. GLP-1 receptor agonists (semaglutide, tirzepatide, others) cause functional gastroparesis – usually transient but can be persistent in some; not true diabetic gastroparesis but similar symptoms.
Test Result Categories
| 4-hour retention | Interpretation |
|---|---|
| Less than 10% | Normal |
| 10-25% | Mild gastroparesis |
| 25-50% | Moderate gastroparesis |
| Greater than 50% | Severe gastroparesis |
Gastroparesis Symptoms
- Nausea (most common).
- Vomiting (sometimes hours after eating).
- Early satiety (feel full after few bites).
- Postprandial fullness/bloating.
- Abdominal pain (variable).
- Weight loss (if severe).
- Heartburn/GERD-like symptoms.
- Anorexia.
- Unexplained blood sugar variability.
- Frequent post-meal hypoglycemia (insulin acts before food absorbed).
- Difficulty taking oral medications.
- Bad breath (food retention).
Indications for Test
- Symptoms suggestive of gastroparesis.
- Unexplained glycemic variability in diabetes.
- Newly intolerant of previously tolerated foods.
- Failed lifestyle/dietary management of GI symptoms.
- Before starting prokinetic medications.
- Refractory GERD without other explanation.
- Differential diagnosis of nausea/vomiting.
- Pre-bariatric surgery evaluation (some surgeons).
Test Preparation
- Off prokinetics 48 hours (Reglan, erythromycin, etc.).
- Off opioids 48 hours if possible.
- Discuss GLP-1 agonist hold with prescriber (may not need to hold for chronic users).
- Hold anticholinergics.
- Fast overnight (8+ hours).
- Blood sugar should be 60-275 mg/dL on day of test.
- Pregnancy test if female of reproductive age.
- Bring list of medications.
- Plan 4-5 hours total time at facility.
- Eat standardized test meal at clinic.
Treatment Approaches
- Glycemic control – well-controlled diabetes slows progression.
- Small frequent meals (5-6 daily) instead of 3 large.
- Low-fat diet (fat delays emptying).
- Low-fiber diet (fiber forms bezoars in stomach).
- Liquids easier to digest than solids.
- Chew thoroughly; eat slowly.
- Avoid carbonated drinks, alcohol.
- Don’t lie down immediately after eating.
- Prokinetic medications – metoclopramide (Reglan), erythromycin, domperidone.
- Antiemetics for nausea – ondansetron, prochlorperazine.
- Avoid opioid pain medications (worsen gastroparesis).
- Gastric electrical stimulation (Enterra) for refractory cases.
- Pylorus-directed therapies – Botox, G-POEM.
- Feeding tube (jejunostomy) for severe cases.
- Address GLP-1 agonist if iatrogenic.
Diabetes Management with Gastroparesis
- CGM device essential – shows erratic glucose patterns.
- Adjust insulin timing – shorter time before meals for rapid-acting.
- Consider extended-action insulin formulations.
- Smaller frequent insulin doses may work better.
- Avoid sulfonylureas if frequent hypoglycemia.
- SGLT2 inhibitors generally safe; some GI side effects.
- Metformin GI symptoms may overlap.
- Address vagal nerve function via blood sugar control.
- Vitamin/mineral supplementation (deficiencies common).
- Liquid nutrition supplements may be needed.
The Bottom Line
Gastric emptying scintigraphy is the gold-standard test for gastroparesis – delayed emptying of food from stomach to small intestine. Procedure – patient eats standardized meal labeled with small amount of radioactive tracer (technetium-99m); images taken at 0, 1, 2, and 4 hours after meal; computer calculates percentage of meal remaining at each time point; total study about 4 hours. Normal results – less than 10% retention at 4 hours. Abnormal – more than 10% (mild), more than 25% (moderate), more than 50% (severe). Other tests – breath tests, wireless motility capsule (SmartPill). For diabetes patients – typical recommendation if symptoms suggestive (nausea, early satiety, vomiting, postprandial fullness, unexplained glycemic variability). Delayed stomach emptying due to nerve damage. Pathophysiology – chronic hyperglycemia damages vagus nerve (autonomic neuropathy) controlling stomach motility; affects 5-50% of long-duration diabetes (many cases mild and asymptomatic). Symptoms – nausea, vomiting, early satiety, postprandial fullness, abdominal pain, bloating, weight loss, GERD-like symptoms, anorexia. Diabetes-specific impact – erratic blood sugar (mismatch between insulin timing and food absorption); difficult medication timing; bezoars; malnutrition; severely impaired quality of life in severe cases. Predisposing factors – long-duration diabetes (10+ years), poorly controlled blood sugar, other diabetic complications, female sex, type 1 more than type 2. GLP-1 receptor agonists (semaglutide, tirzepatide) cause functional gastroparesis. Indications for test – symptoms suggestive of gastroparesis; unexplained glycemic variability; newly intolerant of foods previously tolerated; failed lifestyle/dietary management of GI symptoms; before starting prokinetic medications; differential diagnosis of unexplained nausea/vomiting; refractory GERD. Pre-test requirements – off prokinetics 48 hours; off opioids 48 hours; off GLP-1 agonists if possible (discuss with prescriber); fast overnight; blood sugar 60-275 mg/dL; pregnancy testing if applicable. Treatment – glycemic control; dietary modification (small frequent meals, low-fat, low-fiber, liquids); medications (prokinetics, antiemetics, pain management avoiding opioids); gastric electrical stimulation (Enterra) for refractory cases; pylorus-directed therapies; severe cases – jejunostomy feeding tube. Diabetes management with gastroparesis – CGM essential; adjust insulin timing; smaller frequent doses; avoid sulfonylureas if frequent hypoglycemia. For adults with type 2 diabetes – gastroparesis is underrecognized; consider testing if symptoms or unexplained glycemic variability; treatment is multifaceted; address GLP-1 agonist use if iatrogenic. See our broader diabetic neuropathy guide for context.
